|
|
- 2017
Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A ReviewDOI: 10.1159/000479391 Keywords: Atherosclerosis, Cardiovascular disease, Eicosapentaenoic acid, End-stage renal disease, Icosapent ethyl, Inflammation, Oxidative stress, Omega-3 fatty acids, Hemodialysis Abstract: Patients with end-stage renal disease on hemodialysis have excess cardiovascular disease (CVD) burden with substantially increased CV event rates compared with the general population
|
